The DOI matches its Crossref record; 116 of the 118 references it cites were found in a registry or an index; 11 of the 84 sources its claims cite were checked for support.
The gut microbiota and host health: a new clinical frontier
Open accessAbstract
Over the last 10–15 years, our understanding of the composition and functions of the human gut microbiota has increased exponentially. To a large extent, this has been due to new ‘omic’ technologies that have facilitated large-scale analysis of the genetic and metabolic profile of this microbial community, revealing it to be comparable in influence to a new organ in the body and offering the possibility of a new route for therapeutic intervention. Moreover, it might be more accurate to think of it like an immune system: a collection of cells that work in unison with the host and that can promote health but sometimes initiate disease. This review gives an update on the current knowledge in the area of gut disorders, in particular metabolic syndrome and obesity-related disease, liver disease, IBD and colorectal cancer. The potential of manipulating the gut microbiota in these disorders is assessed, with an examination of the latest and most relevant evidence relating to antibiotics, probiotics, prebiotics, polyphenols and faecal microbiota transplantation.
Overview
CoChat Summary
TL;DR
This narrative review updates the role of the gut microbiota in metabolic/obesity-related disease, liver disease, IBD, and colorectal cancer, and assesses microbiota-modulating therapies including antibiotics, probiotics, prebiotics, polyphenols, and faecal microbiota transplantation. It argues the microbiota is a modifiable, host-specific system with therapeutic and diagnostic potential, while noting that human evidence remains limited by confounding, sampling bias, and equivocal trial results.
Key findings
- The gut microbiota is described as containing “100 times more genes than the host,” with about 160 species in the large intestine of any individual; function appears more conserved across people than species identity, and 10% of daily energy requirements come from colonic fermentation.
- In obesity/metabolic disease, metagenomic studies identified high versus low microbial gene richness (HGC/LGC); LGC was linked to proinflammatory *Bacteroides* spp and oxidative-stress genes, while HGC had more *F. prausnitzii* and butyrate-production potential. FMT from lean donors to metabolic syndrome patients significantly increased insulin sensitivity, faecal butyrate, microbial diversity, and *Roseburia intestinalis*-related bacteria.
- In IBD, the most consistent change is reduced Firmicutes; the IBD metagenome contains “25% fewer genes” than healthy gut. A meta-analysis of FMT in IBD found overall clinical remission in 45% (54/119), and 36% when only cohort studies were analysed.
- In CRC, pathobionts including *Streptococcus gallolyticus*, *Enterococcus faecalis*, *Bacteroides fragilis*, *E. coli*, and *Fusobacterium nucleatum* have been linked with adenomas/CRC; butyrate-producers are reduced, and H₂S is implicated in CRC development.
Methods
- Narrative review of current knowledge and evidence, not a primary study; it synthesizes large-scale microbiome projects, metagenomic/metatranscriptomic studies, animal models, human observational studies, RCTs, and meta-analyses.
- The review covers GI and liver diseases—metabolic syndrome/obesity-related disease, NAFLD/alcoholic/autoimmune liver disease, IBD, and CRC—and evaluates microbiota modulation via antibiotics, probiotics, prebiotics, polyphenols, and FMT.
- No systematic search strategy, inclusion criteria, or formal quality assessment is reported.
Limitations
- The paper states that most data derive from faecal samples, which do not represent the complete gut picture; the small intestine differs markedly from the colon, and most studies come from North America and Europe, giving a biased view.
- It states that human probiotic and prebiotic data are equivocal, with poor study design/strain choice and few well-powered prebiotic trials; obesity links are confounded by diet, host genetics, hormones, lifestyle, and BMI limitations.
- It states that CRC human studies involve small patient numbers, sampling heterogeneity, limited tumour phenotyping, and limited oncological data. Evident from the text: as a narrative review, it lacks systematic methods and formal evidence grading.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
9 Valid · 14 Not valid · 65 Not checked · 31 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“there is growing evidence that the high fat intake rather than obesity per se had a direct effect on the microbiota and linked clinical parameters.26”
§ The gut microbiota and host health: a new clinical frontier > Obesity-related diseases and the gut microbiota
What the sources say
- Partly supportedcites [26] sourceExperimental — accuracy not yet measured
Our copy supports the general thrust: diet-separated groups (DG1 'low fat/high fibre' through DG4 'high fat/low fibre', Concordance of diet and microbiota, p. 7) co-segregated with microbiota composition, microbiota-health links held after adjustment, and the authors 'infer that the causal relationship is in a diet-microbiota-health direction' (Microbiota-health correlations, p. 10; Discussion, p. 12). It also supports the 'rather than obesity per se' contrast in a limited way: 'There was no correlation between the Bacteroidetes : Firmicutes ratio and BMI' (p. 9). Not supported: the paper never isolates high fat intake as the operative variable (its dietary axis combines fat and fibre, with vegetables, fruit and meat as the most discriminating foods), it does not test adiposity as a comparator beyond that single B:F–BMI result, and it reports correlation with an inferred direction rather than a demonstrated 'direct effect'; the cohort is 178 Irish elderly (>65) across community/long-stay settings, not adults generally. (LLM, conf=0.72)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It is now recognised that the gut microbiota and chronic liver diseases are closely linked.”
§ The gut microbiota and host health: a new clinical frontier > Liver disease and the gut microbiota
What the sources say
- Supportedcites [37] Son G , Kremer M , Hines IN . Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010;2010:1–13. doi:10.1155/2010/453563 source
The Concluding Remarks state that gut-derived antigens contribute significantly to various acute and chronic liver diseases and describe a connection between the gut microbiota and liver disease. This supports the broad claim that the two are closely linked, while the paper notes that specific mechanisms remain under investigation. (LLM, conf=0.93)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Analysis of colon biopsy microbiota revealed that patients with PSC-IBD and IBD showed reduced abundance of Prevotella and Roseburia (a butyrate-producer) compared with controls.48 49”
§ The gut microbiota and host health: a new clinical frontier > Liver disease and the gut microbiota > Autoimmune liver diseases
What the sources say
- Not checked yetcites [48] Quraishi, 2014, Probing the microbiota in PSC: the gut adherent microbiota of PSC-IBD is distinct to that of IBD and controls, Hepatol
- Could not verifycites [49] sourceExperimental — accuracy not yet measured
Section 3.6 reports lower uncultured Clostridiales II in PSC patients than in UC patients and controls, but does not report the claimed reductions in Prevotella or Roseburia in PSC-IBD and IBD. A search for Roseburia found no mention; Prevotella appears in the Discussion only in a description of another study, not as a result for these patient groups. Page numbers were not available in our copy. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“A definitive change of the normal gut microbiota with a breakdown of host-microbial mutualism is probably the defining event in IBD development.59”
§ The gut microbiota and host health: a new clinical frontier > IBD and the gut microbiota
What the sources say
- Supportedcites [59] source
The DYSBIOSIS section states the claim almost verbatim, including its qualifier “probably.” (LLM, conf=0.95)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Specifically, ileal CD has been shown to be associated with alterations in bacterial carbohydrate metabolism and bacterial-host interactions, as well as human host-secreted enzymes.69”
§ The gut microbiota and host health: a new clinical frontier > IBD and the gut microbiota
What the sources say
- Supportedcites [69] source
The Results report altered metabolic pathways in ileal Crohn’s disease, including reduced glycolysis and butyrate-production pathways, and increased abundance of bacterial outer-membrane proteins relevant to host interactions. They also report higher levels of pancreatic enzymes in stool from affected subjects. The Discussion links these microbiota changes with altered handling of secreted enzymes; page numbers were not provided. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
53 more claims · 1 with their cited sources checked
Create a free account to see all 119 claims and to verify the 73 references still open.
- It may state two separate claims as one. 50
- Probably not a substantial claim. 17
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, dietary fiber and high consumption of plant-based foods appears to inhibit the bacteria from producing harmful metabolites from proteins, emphasizing the importance of eating adequate complex carbohydrates to maintain gut microbiome carbohydrate fermentation [36].”
From Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes (2016) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“Chronic liver disorders have also been associated with changes in gut microbiome composition and the disruption of the intestinal barrier3,5–8.”
From Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice (2019) · cites this paper as [3]
In the citing paper
“Specific bacteria shown to be more abundant in health compared with disease states include Bifidobacterium and Lactobacillus spp.(2,7,14)”
From Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis (2018) · cites this paper as [2]
In the citing paper
“In the colon and cecum, complex plant-derived polysaccharides are digested and subsequently fermented by gut microorganisms, such as Lactobacillus, Bifidobacterium, Clostridium, Bacteroides, into SCFAs and gases which are also used as carbon and energy sources by specialized bacteria such as reductive acetogens, sulfate-reducing bacteria and methanogens (reviewed by Marchesi et al [36] and by Flin”
From Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes (2016) · cites this paper as [36]
In the citing paper
“P-cresol, phenols, certain amines and hydrogen sulfide have a known role in irritable bowel disease, colon cancer, increased intestinal permeability, inflammation, DNA damage and more [36].”
From Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes (2016) · cites this paper as [36]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“24 Nevertheless, based on most human studies, the obesity-associated decrease in the ratio of Bacteroidetes to Firmicutes (B:F) remains controversial.”
BackgroundDietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“An increase in relative abundance of Firmicutes and a proportional decrease in Bacteroidetes were associated with the microbiota of obese mice, 23 which was con fi rmed in a human dietary intervention study demonstrating that weight loss of obese individuals (body mass index, BMI>30) was accompanied…”
BackgroundMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 1×
“14 In the colon, the majority of this carbohydrate fermentation occurs in the proximal colon, at least for people following a Western style diet.”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Self-citation
Cited by
Natural products in drug discovery: advances and opportunities
Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., Taskforce, T. I. N. P. S., Orhan, I. E., Banach, M., Rollinger, J. M., Barreca, D., Weckwerth, W., Bauer, R., et al. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00114-z · Cited by 5,392
The Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637
Gut microbiota functions: metabolism of nutrients and other food components
Rowland, I., Gibson, G., Heinken, A., Scott, K., Swann, J., Thiele, I., & Tuohy, K. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1445-8 · Cited by 2,878
“More recently evidence has been accumulating that the microbiota may also be involved in obesity and diabetes [4, 5].”
BackgroundImpact of the gut microbiota on inflammation, obesity, and metabolic disease
Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M.-E. (2016) · Genome Medicine · doi:10.1186/s13073-016-0303-2 · Cited by 1,438
“In particular, the gut microbiota is believed to contribute to metabolic diseases via stimulation of low-grade inflammation [13].”
BackgroundInfluentialGut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
Metadata
- Authors
- Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., Thomas, L. V., Zoetendal, E. G., & Hart, A.
- Affiliations
- Imperial College London (GB)
- University of Birmingham (GB)
- Nutrition and Nutrigenomics Group, Department of Food Quality and Nutrition, Research and Innovation Centre, Trento, Italy
- TiFN (NL)
- University of Aberdeen (GB)
- Wageningen University & Research (NL)
- Yakult UK Limited, Middlesex, UK
- St Mark's Hospital (GB)
- Corresponding author
- Hart, Ailsa
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-09-02
- Volume
- 65
- Issue
- 2
- Pages
- 330-339
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4752653
- OpenAlex
- W2129690444
- Cited by
- 2,302
- References
- 118
- Citations by year
- 2026: 126 · 2025: 195 · 2024: 214 · 2023: 224 · 2022: 257 · 2021: 294 · 2020: 258 · 2019: 201 · 2018: 202 · 2017: 209 · 2016: 114 · 2015: 4
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion, cc-by-nc)
- CINECA IRIS Institutional Research Information System (Fondazione Edmund Mach) (submittedVersion, cc-by-nc)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc)
- Funders
- National Institute for Health and Care Research (NF-SI-0512-10080, ACF-2012-09-007)
- Academy of Medical Sciences (AMS-SGCL8-Kinross)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, host health, metabolic syndrome, obesity-related comorbidities, liver disease, inflammatory bowel disease, colorectal cancer, microbiome manipulation, antibiotics, probiotics, prebiotics, polyphenols, fecal microbiota transplantation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Autoimmune Diseases, Bacteria, Colitis, Ulcerative, Crohn Disease, Health Status, Humans, Liver Diseases, Liver Diseases, Alcoholic, Obesity, Inflammatory Bowel Diseases, Pouchitis, Probiotics, Prebiotics, Polyphenols, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The gut microbiota and host health: a new clinical frontier. https://app.cochat.ai/papers/10.1136/gutjnl-2015-309990
- The paper
- Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., Thomas, L. V., Zoetendal, E. G., & Hart, A. (2016). The gut microbiota and host health: a new clinical frontier. Gut. https://doi.org/10.1136/gutjnl-2015-309990
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
